Currently pregnant or breastfeeding-Neither Posts on Medivizor
Navigation Menu

Currently pregnant or breastfeeding-Neither Posts on Medivizor

Does radiotherapy improve outcomes for patients with primary breast diffuse large B-cell lymphoma?

Posted by on Jul 10, 2018 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study evaluated the impact of radiotherapy on the outcomes of rituximab (Rituxan)-treated patients with primary breast diffuse large B-cell lymphoma. This study concluded that radiotherapy has significant therapeutic benefits for these patients. Some background Primary breast diffuse large B-cell lymphoma (DLBCL) is a rare type of...

Read More

Chemotherapy before surgery; is there a different in outcome between different types of breast cancer?

Posted by on May 14, 2015 in Breast cancer | 0 comments

In a nutshell The authors aimed to evaluate if the outcomes of surgery following chemotherapy are different based on the focality of breast cancer tumors.  Some background Breast cancer can be characterised as 'unifocal', 'multifocal and 'multicentric'. This refers to the number of areas in which the cancer can be found...

Read More

An analysis of TNF-blocking agents in combination with methotrexate for active rheumatoid arthritis

Posted by on Apr 13, 2014 in Rheumatoid Arthritis | 0 comments

In a nutshell This analysis investigated the benefits of combined methotrexate (MTX) and tumor necrosis factor (TNF) blockers in the treatment of active rheumatoid arthritis. Some background Rheumatoid arthritis (RA) is characterized by the improper activation of the immune system leading to chronic inflammation and joint damage. Active RA is...

Read More

Can Zometa improve survival rate?

Posted by on Nov 4, 2013 in Breast cancer | 0 comments

In a nutshell This study investigated the influence of zoledronic acid (Zometa) on disseminated tumor cell (DTC) and survival of early stage breast cancer patients. Some background DTC are tumor cells that can be found in the bone marrow (the fatty and bloody tissue that fills the bone cavities and is the source of red blood cells and many white...

Read More

A new treatment option for breast cancer

A new treatment option for breast cancer

Posted by on Sep 23, 2013 in Breast cancer | 1 comment

In a nutshell This phase II clinical trial examined the safety and efficacy of adding a drug called rh-endostatin (Endostar) to chemotherapy in breast cancer patients. Some background Cancer cells need blood supply in order to grow. As cancer grows, it forms its own blood vessels, a process called angiogenesis. Therefore, anti-angiogenesis...

Read More

Evaluating the effect on survival of long-term hormone therapy in breast cancer patients

Posted by on Jul 30, 2013 in Breast cancer | 0 comments

In a nutshell This study examined the impact on survival of more than 5 years of adjuvant hormonal therapy in breast cancer patients. Some background Some types of breast cancer grow in response to female sex hormones (estrogen and progesterone) via their receptor (a protein found on breast cells). These are called hormone receptor-positive (HR+)...

Read More

Low dose tamoxifen as post surgical treatment for ductal intraepithelial neoplasia

Posted by on Jul 28, 2013 in Breast cancer | 0 comments

In a nutshell This study investigated the use of low dose tamoxifen (nolvadex) on tumor recurrence when given as a post surgical treatment for ductal intraepithelial neoplasia. Some background Breast cancer cells which have not yet broken through the tissue layer in which they reside are often called intraepithelial, and are considered to be...

Read More

Disease-free survival in breast cancer patients is increased by adding paclitaxel to FAC chemotherapy

Posted by on Jul 15, 2013 in Breast cancer | 0 comments

In a nutshell In this study researchers examined the effect of a specific chemotherapy combination on disease-free survival in patients with node negative breast cancer. FAC treatment was compared to FAC treatment plus paclitaxel (FACwP). Some background A combination of the drugs fluorouracil (efudex), doxorubicin (doxil), and cyclophosphamide...

Read More

Trastuzumab emtansine as treatment for advanced HER2 positive breast cancer

Posted by on Jul 10, 2013 in Breast cancer | 1 comment

In a nutshell This trial compared treatment with trastuzumab (herceptin) in combination with docetaxel, to a new combination drug called trastuzumab emtansine. Some background Some breast cancer cells have certain receptors on their surface that respond to growth inducing molecules. These cancers are referred to as being human epidermal growth...

Read More

The effect of adding lapatinib to paclitaxel chemotherapy on survival in HER2 positive metastatic breast cancer patients

Posted by on Jul 6, 2013 in Breast cancer | 0 comments

In a nutshell This phase III clinical trial evaluated the effects on survival of the drug lapatinib in combination with a standard chemotherapy agent called paclitaxel in newly diagnosed HER2 positive metastatic breast cancer patients.  Some background Some breast cancer cells have on their surface a protein (receptor) called human epidermal...

Read More